Literature DB >> 24924728

[Severe osteoarthritic manifestations of ochronosis].

U Lange1, U Müller-Ladner, G Dischereit.   

Abstract

The congenital form of ochronosis is a result of the rare autosomal recessive inherited metabolic disease alkaptonuria. The disruption of tyrosine metabolism based on a genetic defect in the enzyme homogentisate dioxygenase results in accumulation of homogentisic acid (HA) which is excreted in the urine and leads to a dark discoloration after a certain incubation time at room temperature. Furthermore, HA polymerizes forming a pigment that is deposited in connective tissues such as tendons, cartilage, bones, intervertebral discs, sclerae, ossicles, cardiac valves and coronary arteries and leads to dark brown discoloration and degeneration. The case of a 74-year-old female patient with ochronosis and classical manifestations is described and in addition a current overview of this rare disease is provided.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24924728     DOI: 10.1007/s00393-013-1343-2

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  13 in total

1.  Deficiency of an enzyme of tyrosine metabolism underlies altered gene expression in newborn liver of lethal albino mice.

Authors:  S Ruppert; G Kelsey; A Schedl; E Schmid; E Thies; G Schütz
Journal:  Genes Dev       Date:  1992-08       Impact factor: 11.361

2.  Alkaptonuria, ochronosis, arthritis and ruptured intervertebral disk complicated by homologous serum reaction.

Authors:  H EISENBERG
Journal:  Arch Intern Med (Chic)       Date:  1950-07

3.  The molecular basis of alkaptonuria.

Authors:  J M Fernández-Cañón; B Granadino; D Beltrán-Valero de Bernabé; M Renedo; E Fernández-Ruiz; M A Peñalva; S Rodríguez de Córdoba
Journal:  Nat Genet       Date:  1996-09       Impact factor: 38.330

4.  Cardiovascular manifestations of Alkaptonuria.

Authors:  Stephen J Pettit; Michael Fisher; James A Gallagher; Lakshminarayan R Ranganath
Journal:  J Inherit Metab Dis       Date:  2011-04-20       Impact factor: 4.982

5.  Characterization of the human fumarylacetoacetate hydrolase gene and identification of a missense mutation abolishing enzymatic activity.

Authors:  Y Labelle; D Phaneuf; B Leclerc; R M Tanguay
Journal:  Hum Mol Genet       Date:  1993-07       Impact factor: 6.150

Review 6.  Alcaptonuria and ochronotic arthritis.

Authors:  B N La Du
Journal:  Mol Biol Med       Date:  1991-02

7.  Alkaptonuria with extensive ochronosis.

Authors:  H W Wyre
Journal:  Arch Dermatol       Date:  1979-04

8.  [Biomechanical studies on the pathogenesis of ochronotic arthropathy].

Authors:  P Eberle; W Mohr; L Claes
Journal:  Z Rheumatol       Date:  1984 Sep-Oct       Impact factor: 1.372

9.  [Ultrastructure of hyaline cartilage and articular capsule tissue in alkaptonuric ochronosis].

Authors:  W Mohr; D Wessinghage; E Lenschow
Journal:  Z Rheumatol       Date:  1980 Mar-Apr       Impact factor: 1.372

10.  Natural history of alkaptonuria.

Authors:  Chanika Phornphutkul; Wendy J Introne; Monique B Perry; Isa Bernardini; Mark D Murphey; Diana L Fitzpatrick; Paul D Anderson; Marjan Huizing; Yair Anikster; Lynn H Gerber; William A Gahl
Journal:  N Engl J Med       Date:  2002-12-26       Impact factor: 91.245

View more
  1 in total

1.  Incidental diagnosis of ochronosis by aortic valve replacement.

Authors:  Özgür Çoban; Hacı Ali Uçak; Muhammet Ahmet Güldür; İbrahim Özsöyler
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2022-01-28       Impact factor: 0.332

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.